Chen Tong, Xu Peng-Cheng, Hu Shui-Yi, Yan Tie-Kun, Jiang Jian-Qing, Jia Jun-Ya, Wei Li, Shang Wen-Ya
Department of Hematology, Tianjin Medical University General Hospital, Tianjin.
Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China.
Medicine (Baltimore). 2019 Feb;98(6):e14428. doi: 10.1097/MD.0000000000014428.
Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here.
A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40 mg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium.
AIN induced by valsartan.
The patient was treated with glucocorticoid.
The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA).
Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary.
血管紧张素受体阻滞剂(ARB)可使肾功能不全、肾动脉狭窄、心力衰竭或血容量不足患者的血清肌酐或血钾水平升高,但在无任何危险因素的患者中几乎不会导致严重肾损伤。本文报告1例缬沙坦诱发的严重急性间质性肾炎(AIN)病例。
一名62岁女性,因恶心1个月、肾功能急性恶化2周入院。她有5个月的高血压病史,服用缬沙坦40毫克/日,共4个月。尽管缬沙坦已停用2周,但入院后血清肌酐仍持续升高。肾活检显示间质有嗜酸性粒细胞浸润。
缬沙坦诱发的AIN。
患者接受糖皮质激素治疗。
血清肌酐逐渐下降,5个月后恢复正常水平,随后停用糖皮质激素治疗。计算机断层血管造影(CTA)排除了肾动脉狭窄。
尽管此前已有缬沙坦诱发过敏的报道,但AIN首次被确认为该药物的严重并发症。我们建议,对于无肾功能不全、肾动脉狭窄、心力衰竭或血容量不足的患者,若出现与ARB相关的肾功能持续恶化,应考虑AIN,并在必要时考虑使用糖皮质激素治疗。